Circ-LDLRAD3 act as a diagnostic biomarker for pancreatic cancer, and its removal suppressed cancer progress6,7 Circ-LDLRAD3 was reported to be upregulated in the plasma of GC patients, suggesting that circ-LDLRAD3 may have a role in the development of GC8. Here, LDLRAD3 is linked to gastric cancer.